Vijay Kumar
PhD Student
Department of Biochemical Engineering
Contact
[email protected]
Bio
Over the duration of his Biomedical Engineering degree, at Swinburne University of Technology, Vijay was particularly intrigued by the role of stem cells and the advancement of biomedical technologies used in clinically directed cell therapies. This motivated him to seek graduate opportunities involving research with stem cells and bioreactors; as a result, he joined the Commonwealth Scientific and Industrial Research Organisation’s (CSIRO) recombinant protein production group as a student trainee. There he was introduced to the large scale production of clinical-grade monoclonal antibodies using stirred tank bioreactors. Based on his interest in stem cells, he also wrote a comprehensive review on mesenchymal stem cell (MSC) expansion methods.
Following his experience at CSIRO, Vijay aspired to pursue a career of research in the field of regenerative medicine; subsequently he progressed to further studies at Monash University, completing a science honours degree through the Department of Anatomy and Developmental Biology. With the majority of research carried out at Hudson Institute of Medical Research, he worked on the expansion of hematopoietic stem cells and MSCs, derived from umbilical cord blood, in therapeutically viable numbers. The project involved the design and development of a fully automated feedback control system equipped to a rotary based perfusion bioreactor incorporating three-dimensional macroporous scaffolds.
Based on his academic background and past research experience, Vijay has been given the opportunity to undertake postgraduate research at UCL in the area of Cell Therapy Bioprocessing under the supervision Dr Farlan Veraitch and Professor Nicolas Szita.
The current project is in collaboration with the Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM) and focuses on the development of mimetic surfaces integrated with novel microfluidic bioreactor technology for the expansion and differentiation of induced pluripotent stem cells.
PhD Student
Department of Biochemical Engineering
Contact
[email protected]
Bio
Over the duration of his Biomedical Engineering degree, at Swinburne University of Technology, Vijay was particularly intrigued by the role of stem cells and the advancement of biomedical technologies used in clinically directed cell therapies. This motivated him to seek graduate opportunities involving research with stem cells and bioreactors; as a result, he joined the Commonwealth Scientific and Industrial Research Organisation’s (CSIRO) recombinant protein production group as a student trainee. There he was introduced to the large scale production of clinical-grade monoclonal antibodies using stirred tank bioreactors. Based on his interest in stem cells, he also wrote a comprehensive review on mesenchymal stem cell (MSC) expansion methods.
Following his experience at CSIRO, Vijay aspired to pursue a career of research in the field of regenerative medicine; subsequently he progressed to further studies at Monash University, completing a science honours degree through the Department of Anatomy and Developmental Biology. With the majority of research carried out at Hudson Institute of Medical Research, he worked on the expansion of hematopoietic stem cells and MSCs, derived from umbilical cord blood, in therapeutically viable numbers. The project involved the design and development of a fully automated feedback control system equipped to a rotary based perfusion bioreactor incorporating three-dimensional macroporous scaffolds.
Based on his academic background and past research experience, Vijay has been given the opportunity to undertake postgraduate research at UCL in the area of Cell Therapy Bioprocessing under the supervision Dr Farlan Veraitch and Professor Nicolas Szita.
The current project is in collaboration with the Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM) and focuses on the development of mimetic surfaces integrated with novel microfluidic bioreactor technology for the expansion and differentiation of induced pluripotent stem cells.